首页> 外文OA文献 >Plasma exosomal microRNA‑125b as a monitoring biomarker of resistance to mFOLFOX6‑based chemotherapy in advanced and recurrent colorectal cancer patients

【2h】

Plasma exosomal microRNA‑125b as a monitoring biomarker of resistance to mFOLFOX6‑based chemotherapy in advanced and recurrent colorectal cancer patients

机译：血浆外泌体MicroRNA-125B作为抗MfolfoX6基化疗的监测生物标志物在先进和复发结直肠癌患者中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Takahiro Yagi; Hisae Iinuma; Tamuro Hayama; Keiji Matsuda; Keijirou Nozawa; Mitsuo Tsukamoto; Ryu Shimada; Takuya Akahane; Takeshi Tsuchiya; Tsuyoshi Ozawa; Yojiro Hashiguchi;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy [J] . En-hai CUI, Hong-jiao LI, Feng HUA, 中国药理学报：英文版 . 2013,第002期

机译：血清microRNA 125b作为接受顺铂化疗的晚期NSCLC患者的诊断或预后生物标志物
2. Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy [J] . ZhaoH.-Y., HuangH., HuZ.-H., Anti-cancer drugs . 2012,第5期

机译：对以卡培他滨为基础的一线化疗治疗的复发/晚期乳腺癌患者对5-氟尿嘧啶和紫杉烷类药物敏感性相关的生物标志物评估
3. A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients [J] . Jia-huan Lu, Zhi-xiang Zuo, Wei Wang, Cell death discovery. . 2018,第1期

机译：基于两个microRNA的特征可预测晚期结直肠癌患者的一线化疗结果
4. Measurement of Angiopoietin 2 tumor biomarker in plasma from colorectal cancer patients by means of a platform based on Bloch surface wave [C] . R. Rizzo, M. Alvaro, N. Danz, European Optical Society annual meeting . 2016

机译：基于Bloch表面波的平台对大肠癌患者血浆中血管生成素2肿瘤生物标志物的测定
5. Inflammation, Type 2 Diabetes, and Cancer: Identifying Biomarkers Associated with Colorectal Cancer and Type 2 Diabetes, and the Use of microRna Molecules as a Therapeutic Use for Cancer Treatment [D] . Guillen, Jenni. 2020

机译：炎症，2型糖尿病和癌症：鉴定与结肠直肠癌和2型糖尿病相关的生物标志物，以及使用MicroRNA分子作为癌症治疗的治疗用途
6. Plasma exosomal microRNA-125b as a monitoring biomarker of resistance to mFOLFOX6-based chemotherapy in advanced and recurrent colorectal cancer patients [O] . Takahiro Yagi, Hisae Iinuma, Tamuro Hayama, -1

机译：血浆外泌体microRNA-125b作为晚期和复发性大肠癌患者对基于mFOLFOX6的化疗耐药的监测生物标志物
7. Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy [O] . En-hai Cui, Hong-jiao Li, Feng Hua, 2012

机译：血清MicroRNA 125B作为接受顺铂化疗的先进NSCLC患者的诊断或预后生物标志物

Plasma exosomal microRNA‑125b as a monitoring biomarker of resistance to mFOLFOX6‑based chemotherapy in advanced and recurrent colorectal cancer patients

著录项

引文网络

相似文献

相关主题

期刊订阅